Aarti Industries Ltd Q2 FY2025 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/b83nohw6mz5kpmd06yv8ifwh.pdf

Key Takeaways


The Quarter: What Happened

Suyog Kotecha: "We accept the fact that as the MMA got launched, I think the volatility increased in terms of performance. At the same time, I want all of us to also look at the fact that because of that 'development', we were actually able to derisk our overall EBITDA performance quite significantly when the rest of the chemical market was down."

The FY28 Bridge: How Management Plans to Get There

Suyog Kotecha: "The numbers that we are currently forecasting as a potential guidance ₹1,800 crores to ₹2,200 crores are very realistic in current market conditions."

MMA: The Volatile Growth Engine

Suyog Kotecha: "Using the term bottoming out, I think is sort of stretching it, because ultimately it depends on how the refinery cracks both gasoline-naphtha delta as well as the gasoline-crude crack evolve over the course of next two, three sort of six, nine, twelve months kind of timeframe where there are multiple other aspects, right, from geopolitics to refinery runs to the demand for gasoline and the impact on that from several other factors."

The China Overcapacity Problem

Suyog Kotecha: "That abnormal profitability and with the base assumption that we will continue to grow at our historical rate is what led to Chinese to expand so massively... that domestic demand of China which was supposed to expect it to grow at historical growth rate actually never materialized... And that's what leads to margin pressure from a near term timeframe."

Long-Term Contracts: The Annuity Base


Organisation, Capital Allocation & New Bets

Rajendra Gogri: "I think we are currently, I would say, we are in very challenging times as well as very exciting times. Challenging is in the sense that volumes are recovering, but the margins of the products are under pressure because in the last two years, post-COVID, in China, a lot of capacities have come up for most of the products, which is tending to keep margins under pressure."

Guidance & Commitments

CommitmentSpecificsTimeline
FY25 EBITDABroadly similar to last year, roughly ₹1,000–1,050 croresFY25 full year
FY28 EBITDA₹1,800–2,200 croresFY28
FY25 capex₹1,300–1,500 croresFY25
FY26 capexAround ₹1,000 croresFY26
Debt-to-EBITDALess than 2.5x (from current ~3x–3.3x)Next two to three years
ROCE targetGreater than 15%No specific date; stated as target
Cost optimisation savings₹150–200 crore EBITDA potentialAccruing over next six to nine months
Acid, DCB, NCB chain utilisationUpwards of 85–90%Next one to one-and-a-half years
Ethylation and NT volume ramp-upGradual ramp-up of newly commissioned capacityNext two years
Contract-three ramp-upRamp to peak levelsFY27 timeframe
Contract-four peakPeak volumesNext 18 months
Contract-six Nitric Acid savingsMajor savings kick inSecond half of FY26
Zone 4 Multipurpose Plant commissioningPlant commissionedMiddle of next year
Zone 4 commercialisationPhase-wise commissioning begins accruingGradually over next 18 months
UPL JV ramp-upVolume and margin ramp-upLatter part of FY28
MMA direct refinery customer scalingScale from 2–3 to 15–20 refineriesTwo to three years
MMA Q3 recoveryOctober/Q3 volumes better than Q2Q3 FY25
Strategic partnershipsHope to conclude someNext six to twelve months
Battery materials commercialisationJoint development, potential commercialisationThree to five years

Key Metrics

MetricQ2 FY25
RevenueNot stated as absolute figure; Energy segment contributed 32% of revenue, down from 41% in Q1
EBITDA₹202 cr, down from ₹311 cr in Q1 FY25
H1 FY25 EBITDA₹512 cr, up 18% YoY from ₹434 cr in H1 FY24
H1 FY25 PAT₹189 cr, versus ₹160 cr in H1 FY24
Exceptional income₹2.3 cr, from divestment of stake in a step-down subsidiary
Full-year FY25 EBITDA guidance₹1,000 cr to ₹1,050 cr, broadly similar to last year; previous guidance of ₹1,500 cr cut by 40%
FY28 EBITDA target₹1,800 cr to ₹2,200 cr, driven by volume growth, operating leverage, and cost optimisation
Non-energy volume growth~22% YoY, across dyes, pigments, polymer additives; agrochemicals remain soft
Energy business (MMA) volume change36% QoQ decline in Q2, from ~31 KT in Q1 to 20.5 KT
Aggregate entity-level volume growth15% YoY
MMA capacity~200 KTPA, expansion completed in Q2; can expand further with minor investment
Energy Additives segment revenue share (H1 FY25)37% of total revenue, 77% export, 23% domestic
Agrochem & Fertilisers revenue share~19% of total revenue, 40:60 export:domestic mix
Dyes, Pigments & Printing Inks revenue share~12% of total revenue, 72% domestic, 28% export
Pharmaceuticals revenue share~9% of total revenue, 99% domestic; growing at 8% to 9% per annum
Polymer & Additives revenue share~13% of total revenue, 85% exports, 15% domestic
Cost optimisation EBITDA potential₹150 cr to ₹200 cr, from steam, power, fixed cost, and yield improvements; savings expected over next 6 to 9 months
Volume and margin ramp-up EBITDA upside₹350 cr to ₹550 cr, from expanded capacities over next 2 to 3 years
Capex-led growth EBITDA contribution₹300 cr to ₹450 cr, from FY25 to FY28 timeframe
FY25 Capex₹1,300 cr to ₹1,500 cr, reduced from earlier estimate of ₹1,500 cr to ₹1,800 cr; ₹670 cr spent in H1
FY26 Capex~₹1,000 cr, combination of maintenance and zone 4
Renewable power target>70% of external power purchase from renewable sources by end of 2026
Debt-to-EBITDA~3x to 3.3x currently; management target less than 2.5x, to be achieved in next 2 to 3 years
ROCE target>15%
MMA client development timeline4 to 8 months per new client in normal scenario
MMA refineries currently supplied2 to 3 refineries; potential to scale to 15 to 20 refineries over 2 to 3 years
Global MTBE market size~3.5 crore tons annually
Long-term contract (Contract-two, Polymer Additives)Operating at highest historical throughput this year
Contract-three ramp-up timelineExpected to reach peak levels by FY27
Contract-four peak timelineExpected within next 18 months
Contract-six (Nitric Acid sourcing) savingsMajor savings to kick in from H2 FY26
NT and Ethylation capacity expansionExpanded from 10 KT to 25-30 KT, commissioning in progress
PDA chain capacity contextChina capacity at 5x to 6x of global demand for some molecules